On diabetic foot, wound healing, amputation prevention, and the merger of consumer tech with medical devices
A cost-effectiveness analysis of the DIAFOS trial shows that in-shoe plantar pressure-guided custom footwear saves over €8,000 per ulcer prevented — and adherent patients push the probability of cost-effectiveness to 94%. The economic case for prevention just got stronger.
A new bibliometric analysis from Wei and colleagues at Capital Medical University in Beijing maps 25 years (2000–2024) of global research on plantar pressure and diabetic foot ulcers — over 2,100 publications indexed in the Web of Science Core Collection. The findings tell a story that will feel familiar to many of us who have... Continue Reading →
A new systematic review finds that roughly one in three adults in remission after a healed diabetic foot ulcer develop a recurrent ulcer within 12 months — a risk comparable to several common cancers. Healing is the beginning of the next chapter, not the end of the story.
Reflecting on 30 Years of Evidence-Based Diabetic Foot Care The International Working Group on the Diabetic Foot (IWGDF) has recently published a commentary marking three decades of its influential guidelines for managing diabetes-related foot disease. Authored by van Netten et al. (2023) and published in Diabetes Therapy, this piece offers a comprehensive overview of the... Continue Reading →
This is great work from Viv Chuter and the rest of the IWGDF team
Here is the link to the guidelines for peripheral artery disease in people with diabetes. Diabetes-related foot complications have become a major cause of morbidity and are implicated in most major and minor amputations globally. Approximately 50% of people with diabetes and a foot ulcer have peripheral artery disease (PAD) and the presence of PAD... Continue Reading →
